NTB003

· Nanjing Chia-tai Tianqing Pharmaceutical

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NTB003, covering 2025-09-19 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED) [Phase 1, Phase 2]